drugset / Trial / NCT00839631

Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors

NCT00839631 ↗

Phase 1 Completed 23 enrolled Dendreon
NaSingle-groupOpen-labelTreatment

Summary

This is a Phase 1, dose escalation study evaluating safety and pharmacokinetics of enteric coated D-3263 HCl in subjects with advanced solid tumors

Timeline

Start
2009-03
Primary completion
2011-12
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject D-3263 Unknown 50 mg Oral

Indications